(Q50955712)

English

Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.

scientific article published in September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

9

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

7

object named as

M Simrén

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

author name string

R Dahlén

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

H Strid

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

A Lundgren

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

S Isaksson

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

S Raghavan

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

M K Magnusson

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

H Sjövall

8

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

publication date

1 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

78

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

275-284

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

The fundamental basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Medical therapy for ulcerative colitis 2004.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Tumor necrosis factor signaling.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Predictors of early response to infliximab in patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Differential effects of the tumor necrosis factor alpha-blocker infliximab and etanercept on immunocompetent cells in vitro

1 reference

https://api.crossref.org/works/10.1111%2FSJI.12081

21 January 2018

Identifiers

10.1111/SJI.12081

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23713660

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50955712&oldid=1062714732"